Overview

A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication

Status:
Completed
Trial end date:
2019-08-31
Target enrollment:
Participant gender:
Summary
We aim to assess and compare the effectiveness of clarithromycin- and furazolidone-based regimens as primary therapies in eradicating H. pylori.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Treatments:
Bismuth
Clarithromycin
Furazolidone